ResearcherSemmelweis UniversityNo recent work listed
Nha Ngoc Hoa Le
Matched on ORCID iD 0000-0003-3388-3439; OpenAlex author ID A5046638351. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2015: 1 paper · 2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper
Papers 4
- Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. Co-author DOI 10.1016/j.pan.2018.10.003↗
- Prognostic and predictive markers in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.dld.2015.11.001↗
- Real-World Clinical Practice of Intensified Chemotherapies for Metastatic Pancreatic Cancer: Results from a Pan-European Questionnaire Study. Co-author DOI 10.1159/000453257↗
- New Advances in the Treatment of Metastatic Pancreatic Cancer. Co-author DOI 10.1159/000439523↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marvin Schober · 4 shared papers, 2015–2019 · strength 0.25
- Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
- Paper Prognostic and predictive markers in pancreatic adenocarcinoma. DOI 10.1016/j.dld.2015.11.001↗
- Paper Real-World Clinical Practice of Intensified Chemotherapies for Metastatic Pancreatic Cancer: Results from a Pan-Europea… DOI 10.1159/000453257↗
- Sebastian Krug · 4 shared papers, 2015–2019 · strength 0.25
- Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
- Paper Prognostic and predictive markers in pancreatic adenocarcinoma. DOI 10.1016/j.dld.2015.11.001↗
- Paper Real-World Clinical Practice of Intensified Chemotherapies for Metastatic Pancreatic Cancer: Results from a Pan-Europea… DOI 10.1159/000453257↗
- Malin Sund · 4 shared papers, 2015–2019 · strength 0.25
- Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
- Paper Prognostic and predictive markers in pancreatic adenocarcinoma. DOI 10.1016/j.dld.2015.11.001↗
- Paper Real-World Clinical Practice of Intensified Chemotherapies for Metastatic Pancreatic Cancer: Results from a Pan-Europea… DOI 10.1159/000453257↗
- Muhammad Ahsan Javed · 3 shared papers, 2015–2019 · strength 0.18
- Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
- Paper Real-World Clinical Practice of Intensified Chemotherapies for Metastatic Pancreatic Cancer: Results from a Pan-Europea… DOI 10.1159/000453257↗
- Paper New Advances in the Treatment of Metastatic Pancreatic Cancer. DOI 10.1159/000439523↗
- Albrecht Neeße · 3 shared papers, 2015–2019 · strength 0.18
- Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
- Paper Real-World Clinical Practice of Intensified Chemotherapies for Metastatic Pancreatic Cancer: Results from a Pan-Europea… DOI 10.1159/000453257↗
- Paper New Advances in the Treatment of Metastatic Pancreatic Cancer. DOI 10.1159/000439523↗
- Georg Beyer · 3 shared papers, 2015–2019 · strength 0.18
- Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
- Paper Real-World Clinical Practice of Intensified Chemotherapies for Metastatic Pancreatic Cancer: Results from a Pan-Europea… DOI 10.1159/000453257↗
- Paper New Advances in the Treatment of Metastatic Pancreatic Cancer. DOI 10.1159/000439523↗
- Salma Moona Alam · 1 shared paper, 2019 · strength 0.07
- Yuk Ting Ma · 1 shared paper, 2019 · strength 0.07
- Ángela Lamarca Lete · 1 shared paper, 2019 · strength 0.07
- Patrick Maisonneuve · 1 shared paper, 2019 · strength 0.07
- Daniel H. Palmer · 1 shared paper, 2019 · strength 0.07
- Lívia Archibugi · 1 shared paper, 2019 · strength 0.07
- Gabriele Capurso · 1 shared paper, 2019 · strength 0.07
- Richard A Hubner · 1 shared paper, 2019 · strength 0.07
- Juan W. Valle · 1 shared paper, 2019 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.